RBC, GILD, ACLS, LMNX, SWI, SYA Expected To Be Up After Next Earnings Releases
Feb 01, 2013 (M2 PRESSWIRE via COMTEX) --
BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Monday, February 4th 2013 and determining how the stocks have performed After their last 12 quarterly, 6 quarterly and February earnings reports. Regal Beloit Corp (NYSE:RBC), GILEAD SCIENCES, INC. (NASDAQ:GILD), Axcelis Technologies Inc (NASDAQ:ACLS), LUMINEX CORPORATION (NASDAQ:LMNX), SolarWinds Inc (NYSE:SWI), Symetra Financial Corp (NYSE:SYA) are all expected to be Up After their earnings are released. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go Up After earnings are released Monday:
Symbol Company # of Reports Quarter Release Time
RBC Regal Beloit Corp February Earnings Q4 After
GILD GILEAD SCIENCES, INC. 6 Quarter Q4 After
ACLS Axcelis Technologies Inc 6 Quarter Q4 After
LMNX LUMINEX CORPORATION February Earnings Q4 After
SWI SolarWinds Inc 12 Quarter Q4 After
SYA Symetra Financial Corp 6 Quarter Q4 After
This technology is designed to help the stock trader identify those companies that seem to have a consistent pattern of movement before or after the earnings release date, based on the history of earnings releases for that company. It combines a calendar of expected earnings releases with a history of past earnings releases in a way that lets you see if a pattern exists.
Regal Beloit Corp (NYSE:RBC) - Regal Beloit Corporation, together with its subsidiaries, manufactures and sells electric motors and controls, electric generators and controls, and mechanical motion control products in the United States, Asia, and internationally. The company operates in two segments, Electrical and Mechanical. The Electrical segment offers AC and DC commercial, industrial, and commercial refrigeration electric motors and blowers, as well as heating, ventilation, and air conditioning (HVAC) electric motors and blowers. It also provides precision servo motors, automatic transfer switches and paralleling switchgear, and control electric power generation equipment; AC and DC variable speed drives and controllers, and other accessories for industrial and commercial applications; and capacitors for use in HVAC systems, high intensity lighting, and other applications, as well as distributes mechanical power transmission components and solutions; and rewinds and distributes electric motors and generators. The Mechanical segment manufactures and markets a range of mechanical motion control products, including worm gears, bevel gears, helical gears, and concentric shaft gearboxes; marine transmissions; custom gearing; gear motors; manual valve actuators; and electrical connecting devices. The company sells its products to original equipment manufacturers, distributors, and end users through its direct sales people and manufacturer s representative organizations. Regal Beloit Corporation was founded in 1955 and is based in Beloit, Wisconsin..
GILEAD SCIENCES, INC. (NASDAQ:GILD) - Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes human therapeutics for the treatment of life threatening diseases worldwide. Its products include Atripla, Truvada, Viread, Complera/Eviplera, and Emtriva for the treatment of human immunodeficiency virus (HIV) infection in adults; Viread and Hepsera oral formulations for the treatment of chronic hepatitis B; Letairis, an oral formulation for pulmonary arterial hypertension; Ranexa, a tablet for chronic angina; Lexiscan/Rapiscan, a test that detects and characterizes coronary artery disease; Cayston, an inhaled antibiotic for the treatment of respiratory systems in cystic fibrosis patients; Tamiflu, a capsule for the treatment and prevention of influenza A and B. The company also provides other products, such as AmBisome, an antifungal agent to treat serious invasive fungal infections; Vistide, an antiviral medication for the treatment of cytomegalovirus retinitis in patients with AIDS; and Macugen, an anti-angiogenic oligonucleotide to treat neovascular macular degeneration. In addition, it has product candidates in various stages for the treatment of HIV, which include integrase single-tablet regimen Quad; Cobicistat and Elvitegravir in Phase III; and GS-7340 in Phase II, as well as for liver disease, which consist of GS-7977 in Phase III; GS-5885, GS-9451, and GS-6624 in Phase II; and GS-7340, GS-9620, and GS-9669 in Phase I. Further, the company s product candidates in various stages for the treatment of cardiovascular/metabolic diseases comprise Ranolazine in Phase III; and for the treatment of respiratory diseases consist of Aztreonam for inhalation solution in Phase III, as well as GS-6624 in Phase I. Additionally, it has product candidates in various stages for inflammation/oncology diseases that include GS-1101 in Phase III; GS-1101 and GS-6624 in Phase II; and GS-9973 in Phase I. The company was founded in 1987 and is headquartered in Foster City, California..
Axcelis Technologies Inc (NASDAQ:ACLS) - Axcelis Technologies, Inc. designs, manufactures, and services ion implantation, dry strip, and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia. It offers high energy implanters, such as Optima XEx, a single wafer tool for high energy applications; high current implanters comprising Optima HDx, a single wafer product for high current applications; and medium current implanters, including Optima MDxt for medium current applications. The company s dry strip tools comprise the Integra RS and ES that include paired-chamber process modules for use in memory and logic devices. In addition, it provides aftermarket service and support, including spare parts, equipment upgrades, and maintenance services to the semiconductor industry. The company sells its equipment and services through direct sales force, distributors, and manufacturing representatives. Axcelis Technologies was founded in 1995 and is headquartered in Beverly, Massachusetts..
LUMINEX CORPORATION (NASDAQ:LMNX) - Luminex Corporation engages in the development, manufacture, and sale of proprietary biological testing technologies and products for the life sciences and diagnostic industries. It offers xMAP technology, an open architecture and multiplexing technology that allows simultaneous analysis of approximately 500 bioassays from a drop of fluid by reading biological tests on the surface of microscopic polystyrene beads called microspheres. The company s xMAP technology is used in various segments of the life sciences industry, such as the fields of drug discovery and development, clinical diagnostics, genetic analysis, bio-defense, food safety, and biomedical research. It operates in two segments, Technology and Strategic Partnerships; and Assays and Related Products. The Technology and Strategic Partnerships segment provides Luminex LX 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; and MAGPIX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids. This segment also offers consumables comprising dyed polystyrene microspheres and sheath fluids. The Assays and Related Products segment develops and sells assays on xMAP technology for use on its installed base of systems. This segment s products are focused on the human genetics, personalized medicine, and infectious disease segments of the genetic testing market. This segment provides various assay products, which consist of a combination of chemical and biological reagents, and company s proprietary bead technology used to perform diagnostic and research assays on samples. It serves pharmaceutical companies, clinical laboratories, research institutions, and medical institutions in the United States, Europe, Asia, Canada, and Australia. The company was founded in 1995 and is headquartered in Austin, Texas..
SolarWinds Inc (NYSE:SWI) - SolarWinds, Inc. designs, develops, markets, sells, and supports enterprise information technology (IT) infrastructure management software for IT professionals in various organizations in the United States and internationally. The company offers enterprise-class IT management products, including Network Performance Monitor, a server-based fault and performance management platform to minimize network downtime; Network Performance Monitor modules, a series of add-ons; network configuration manager to automate the processes of network device discovery, network inventory management, and network change management; user device tracker, a server-based switch port management tool; scalability engines to increase the scale of a number of the products; and enterprise operations console to provide web-based views of various instances of Network Performance Monitor modules and Application Performance Monitor. Its enterprise-class network and IT management products also comprise Application Performance Monitor, a server-based availability and performance management system for applications and server infrastructure; patch manager to automate the process of deploying, managing, and reporting on patches and configuration settings; and synthetic end user monitor to capture the user steps of any web application and monitor the end-user experience; storage manager that combines reporting, monitoring, and notification on the performance of storage resources; backup profiler to provide a consolidated view of the status of backup operations; virtualization manager to manage various aspects of virtual server infrastructure; and log and event manager to automate the collection and interpretation of logs. In addition, the company provides free tools, such as desktop, laptop, server-based, or internet-based applications; and tools and toolsets for specific solutions of routine and complicated tasks. The company was founded in 1999 and is headquartered in Austin, Texas..
Symetra Financial Corp (NYSE:SYA) - Symetra Financial Corporation, through its subsidiaries, provides group and individual insurance products and retirement products in the United States and the District of Columbia. Its Benefits division offers medical stop-loss insurance, limited benefit medical insurance, group life insurance, accidental death and dismemberment insurance, and disability income insurance products to employers, unions, and public agencies with 50 to 5,000 employees, as well as provides managing general underwriting services. The company s Retirement division offers fixed and variable deferred annuities to consumers who accumulate tax-deferred assets for retirement; single premium immediate annuities to customers seeking a reliable source of retirement income or to protect against outliving their assets during retirement; structured settlement annuities to fund third party personal injury settlements; and funding services options to structured settlement clients. Its Life division provides various individual products, such as term and universal life insurance, including single premium life insurance, as well as bank-owned life insurance. The company distributes its products through a network of benefits consultants, financial institutions, independent agents and advisers, third party administrators, employee benefits brokers, brokerage general agents, specialty agents, and administrative services only arrangements. Symetra Financial Corporation was founded in 1957 and is headquartered in Bellevue, Washington..
SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com
www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.
INVESTMENTS & TRADING
SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.
SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.
All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.
Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.
By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.
Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.
Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.
"Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.
Thomas Ronk, CEO
SqueezeTrigger is a registered trademark, Reg. No. 3,120,641
((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to email@example.com.
[ Back To Contact Center Solutions's Homepage ]